News
03-11-2010, 05:15 AM
Women's responsiveness to the second-line breast cancer drug fulvestrant may depend on whether the cancer cells are expressing two key proteins, Indiana University Bloomington scientists report in this month's Cancer Biology & Therapy...
More... (http://mnt.to/f/3yLw)
More... (http://mnt.to/f/3yLw)